Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Liver function may change how lung cancer drug works

NCT ID NCT07538973

First seen Apr 28, 2026 · Last updated Jun 18, 2026 · Updated 7 times

Summary

This early-stage study looks at how the drug anecatibin fumarate is processed in the body of people with and without liver problems. It will include 24 adults with lung cancer. The goal is to understand safety and drug levels, not to test if the drug works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Qingdao University Affiliated Hospital

    Qingdao, Shandong, 266000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xiamen Traditional Chinese Medicine Hospital

    Xiamen, Fujian, 361000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhengzhou Sixth People's Hospital

    Zhengzhou, Henan, 450015, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

liver disorder lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.